CC
Commodore Capital Portfolio holdings
AUM
$1.42B
This Quarter Return
+50.84%
1 Year Return
+73.3%
3 Year Return
+1,330.82%
5 Year Return
–
10 Year Return
–
AUM
$1.14B
AUM Growth
+$1.14B
(+34%)
Cap. Flow
+$97.3M
Cap. Flow
% of AUM
8.5%
Top 10 Holdings %
Top 10 Hldgs %
62.98%
Holding
38
New
8
Increased
7
Reduced
7
Closed
6
Top Buys
| 1 |
Arvinas
ARVN
|
$41.2M |
| 2 |
Spyre Therapeutics
SYRE
|
$38M |
| 3 |
Nuvalent
NUVL
|
$37M |
| 4 |
Pharvaris
PHVS
|
$22.4M |
| 5 |
C4 Therapeutics
CCCC
|
$21.5M |
Top Sells
| 1 |
AMAM
Ambrx Biopharma, Inc. Common Stock
AMAM
|
$40.5M |
| 2 |
Rhythm Pharmaceuticals
RYTM
|
$24.1M |
| 3 |
IDEAYA Biosciences
IDYA
|
$20.9M |
| 4 |
Crinetics Pharmaceuticals
CRNX
|
$14.9M |
| 5 |
Cabaletta Bio
CABA
|
$14.2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Dyne Therapeutics
DYN
$1.92B
| $12M | 1.05% |
+900,000
| New | +$12M |
|
27
VistaGen Therapeutics
VTGN
$102M
| $8.1M | 0.71% |
1,575,000
| – | – |
|
|
THRD
28
DELISTED
Third Harmonic Bio
THRD
| $7.75M | 0.68% |
706,706
-993,294
| -58% | -$10.9M |
|
29
Adverum Biotechnologies
ADVM
$64.6M
| $7.53M | 0.66% |
10,000,000
| – | – |
|
30
Apogee Therapeutics
APGE
$2.17B
| $6.99M | 0.61% |
250,000
| – | – |
|
31
SAB Biotherapeutics
SABS
$19.3M
| $1.26M | 0.11% |
+1,831,746
| New | +$1.26M |
|
|
DBVT
32
DBV Technologies
DBVT
$264M
| $88.3K | 0.01% |
92,687
| – | – |
|
|
33
Crinetics Pharmaceuticals
CRNX
$2.92B
| – | – |
-500,000
| Closed | -$14.9M |
|
34
Day One Biopharmaceuticals
DAWN
$769M
| – | – |
-739,661
| Closed | -$9.08M |
|
|
35
IDEAYA Biosciences
IDYA
$2.15B
| – | – |
-775,000
| Closed | -$20.9M |
|
36
Mersana Therapeutics
MRSN
$36.5M
| – | – |
-2,244,378
| Closed | -$2.85M |
|
37
Syndax Pharmaceuticals
SNDX
$1.41B
| – | – |
-957,509
| Closed | -$13.9M |
|
|
AMAM
38
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| – | – |
-3,518,556
| Closed | -$40.5M |
|